Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Regen Biopharma, Inc.”

4 pharma patents match "Regen Biopharma, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "Regen Biopharma, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “Regen Biopharma, Inc.” · 30,257 patents in full index Clear search

  1. US 11712474

    Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition

    Regen Biopharma, Inc. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted

  2. US 11090332

    Antigen specific mRNA cellular cancer vaccines

    Regen Biopharma, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  3. US 10088485

    Methods of screening compounds that can modulate NR2F6 by displacement of a reference ligand

    Regen Biopharma, Inc. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  4. US 9091696

    Modulation of NR2F6 and methods and uses thereof

    Regen Biopharma, Inc. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.